These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1185526)

  • 1. Editorial: Harmless, but ineffective, remedies.
    Feldmann EG
    J Pharm Sci; 1975 Oct; 64(10):I. PubMed ID: 1185526
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical quackery in Rhode Island: the perspective of state and federal drug control agencies.
    Fairfield PB; Hachadorian C
    R I Med J (1976); 1990 Apr; 73(4):145-7. PubMed ID: 2336519
    [No Abstract]   [Full Text] [Related]  

  • 3. Laetrile: the making of a myth.
    FDA Consum; 1976 Dec-1977 Jan; 10(10):5-8. PubMed ID: 10304521
    [No Abstract]   [Full Text] [Related]  

  • 4. Combatting medical quackery: a message to the physicians of Rhode Island.
    Scott HD
    R I Med J (1976); 1990 Apr; 73(4):141-3. PubMed ID: 2336518
    [No Abstract]   [Full Text] [Related]  

  • 5. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA bans 223 ingredients in nonprescription drug products.
    Clin Pharm; 1991 Feb; 10(2):88, 93. PubMed ID: 2009736
    [No Abstract]   [Full Text] [Related]  

  • 7. Little common ground seen in proposed U.S. laws vs. regulations on dietary supplements.
    Nutrition; 1993; 9(5):478. PubMed ID: 8286892
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct-to-OTC marketing of drugs: possible approaches.
    Mahinka SP; Bierman ME
    Food Drug Law J; 1995; 50(1):49-63. PubMed ID: 10342985
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: The FDA and the pharmacist as an advisor on nonprescription drugs.
    Zellmer WA
    Am J Hosp Pharm; 1974 May; 31(5):447. PubMed ID: 4829385
    [No Abstract]   [Full Text] [Related]  

  • 10. Ugly wait at the counter. Insurer pushes to make allergy drugs nonprescription.
    Benko LB
    Mod Healthc; 2001 Aug; 31(32):22-3. PubMed ID: 11507861
    [No Abstract]   [Full Text] [Related]  

  • 11. Steps taken to lessen tampering with OTC drugs.
    FDA Drug Bull; 1983 Apr; 13(1):6. PubMed ID: 6852409
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer quackery--the past in the present.
    Janssen WF
    Semin Oncol; 1979 Dec; 6(4):526-36. PubMed ID: 394334
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of cosmetics that are also drugs.
    Greff JA
    Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201
    [No Abstract]   [Full Text] [Related]  

  • 14. Laetrile in historical perspective.
    Kardinal CG
    Mo Med; 1980 Sep; 77(9):564-9. PubMed ID: 7001210
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of the Task Force on the future of OTC drugs.
    Collins DE
    Food Drug Law J; 2000; 55(1):27-31. PubMed ID: 12269359
    [No Abstract]   [Full Text] [Related]  

  • 16. The cancer "cures": a challenge to rational therapeutics.
    Janssen WF
    Anal Chem; 1978 Feb; 50(2):197A-202A. PubMed ID: 341747
    [No Abstract]   [Full Text] [Related]  

  • 17. Once more into the breach, dear friends.
    Owen JA
    Hosp Formul; 1977 Aug; 12(8):491. PubMed ID: 10236479
    [No Abstract]   [Full Text] [Related]  

  • 18. "Tag--we're it".
    Czap A
    Altern Med Rev; 2003 May; 8(2):104. PubMed ID: 12777156
    [No Abstract]   [Full Text] [Related]  

  • 19. The courts, terminal patients, and unapproved drugs.
    Janssen W
    FDA Consum; 1979 Nov; 13(9):4-7. PubMed ID: 10309109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. View from the Nation's Capital. FDA moves forward (and backwards) on a number of simmering issues.
    Appler WD
    J Clin Psychopharmacol; 1988 Feb; 8(1):57-8. PubMed ID: 3351001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.